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and Edward Hough1*
Background: The phospholipase D (PLD) superfamily includes enzymes that
are involved in phospholipid metabolism, nucleases, toxins and virus
envelope proteins of unknown function. PLD hydrolyzes the terminal
phosphodiester bond of phospholipids to phosphatidic acid and a
hydrophilic constituent. Phosphatidic acid is a compound that is heavily
involved in signal transduction. PLD also catalyses a transphosphatidylation
reaction in the presence of phosphatidylcholine and a short-chained primary
or secondary alcohol.
Results: The first crystal structure of a 54 kDa PLD has been determined to
1.9 Å resolution using the multiwavelength anomalous dispersion (MAD)
method on a single WO4 ion and refined to 1.4 Å resolution. PLD from the
bacterial source Streptomyces sp. strain PMF consists of a single polypeptide
chain that is folded into two domains. An active site is located at the interface
between these domains. The presented structure supports the proposed
superfamily relationship with the published structure of the 16 kDa
endonuclease from Salmonella typhimurium. 
Conclusions: The structure of PLD provides insight into the structure and
mode of action of not only bacterial, plant and mammalian PLDs, but also of a
variety of enzymes as diverse as cardiolipin synthases, phosphatidylserine
synthases, toxins, endonucleases, as well as poxvirus envelope proteins having
a so far unknown function. The common features of these enzymes are that they
can bind to a phosphodiester moiety, and that most of these enzymes are active
as bi-lobed monomers or dimers.
Introduction
Phospholipase D (PLD) is a ubiquitous enzyme that has
been found in a variety of species, for example, plants,
mammals and microorganisms. In addition to its
hydrolytic activity, PLD catalyzes a transesterification
(transphosphatidylation) reaction when alcohol is present
as a nucleophilic donor. From this transesterification
reaction it is possible to synthesize naturally occurring,
low abundance phospholipids such as phosphatidyl-
ethanolamine, -serine and -glycerol, from high abun-
dance ones, such as phosphatidylcholine. These and
other phospholipids have various applications in the
pharmaceutical and food industries, as well as in other
fields [1,2]. PLDs from microbial species have a broader
specificity for transphosphatidylation activity than PLD
from plants (e.g. cabbage [3,4]), which makes the micro-
bial enzymes more interesting for industrial applications
of the transphosphatidylation reaction than the plant and
mammalian ones. In addition to their contribution to
phospholipid metabolism, PLD enzymes are involved in
vesicle formation, protein transport, signal transduction
and mitosis [5]. One of the products of the hydrolytic
action of PLD, phosphatidic acid (PA), is a putative
second messenger. Under certain circumstances, the for-
mation of phosphatidic acid is also suggested to cause
changes in lipid bilayer properties that would facilitate
fusion events and vesicle budding in the course of intra-
cellular membrane traffic [6]. The metabolic fates of PA
are the conversion into cytidine diphosphate-diacylglyc-
erol (CDP-DAG) for resynthesis of certain phospholipids;
and the formation of two second messengers, diacylglyc-
erol (DAG) and lysophosphatidic acid (LPA), the latter
being PA lacking one of the fatty acid chains because of
hydrolytic removal [5]. Recently, PLD has been shown to
be part of a superfamily [7–9] that includes all the PLDs
sequenced so far, cardiolipin synthases, phosphatidyl
serine synthases, a Yersinia murine toxin, poxvirus enve-
lope proteins and several endonucleases. It is interesting
that, with a few exceptions, members of the PLD super-
family share two copies of the conserved sequence motif
HXK(X)4D (in single-letter amino acid code and where X
is any amino acid), denoted the HKD motif. The excep-
tion being some of the endonucleases, which only have
one such domain, and some poxvirus envelope protein
homologues, which show only partial conservation of one
of the HKD motifs (conserved as NXK(X)4D). It has
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been speculated that the lack of the histidine residue in
the poxvirus enzymes renders them unable to act as cata-
lysts. Recently, the structure of one of the members of
the PLD superfamily, endonuclease (nuc) from Salmo-
nella typhimurium, was solved [10]. It is capable of
hydrolyzing double- and single-stranded DNA and the
artificial subtrate, bis (4-nitrophenyl) phosphate [11].
This endonuclease is one of the enzymes in the PLD
superfamily that only has one conserved HKD motif and
it consists of only 155 residues. It crystallizes as a dimer
[10], however, and clearly supports the theory of an
ancient gene duplication and splicing event from an
ancestral gene for the majority of the members of the
PLD superfamily of enzymes [9].
The primary and three-dimensional structures of PLD
from Streptomyces sp. strain PMF were determined using
the multiwavelength anomalous dispersion (MAD)
phasing method [12]. Additional solvent-flattening tech-
niques, histogram matching and phase extension of the
MAD phases onto the native structure factors extended
the working resolution of the maps to 1.4 Å. The present
model describes visible regions in electron density and
comprises 494 amino acid residues, 2 phosphates and
644 water molecules, with crystallographic R factors of
12.97% and 18.23% for the working and test sets of
reflections, respectively.
This paper describes the three-dimensional structure of
PLD from Streptomyces sp. strain PMF. As sequence infor-
mation was available for only about 40% of the amino
acids, most of the primary sequence was identified from
inspection of the 1.4 Å electron-density maps.
Results and discussion
The structure of PLD from Streptomyces sp. strain PMF
includes 35 secondary structure elements as defined by
the Dictionary of Secondary Structures in Proteins
(DSSP) [13], forming two β sheets, with nine and eight 
β strands, respectively. There are 18 α helices that flank
the two β sheets; two of these have a somewhat irregular
orientation, running diagonally on one side of each of the
β sheets. An overall view of the structure of PLD from
Streptomyces sp. strain PMF is shown in Figure 1 and the
topology of the protein is shown in Figure 2a. A stereo-
graphic overview of the tertiary architecture of the
protein is presented in Figure 2b and a stereographic
illustration of the Cα trace is shown in Figure 2c. The
two β sheets are sandwiched between surrounding
α helices, with the more usual orientation of the helices
on the water-exposed side of each β sheet. The α helices
α8 and α16–α17 (Figure 2a) lie between the β sheets and
are rotated with respect to the general strand direction.
The overall structure of PLD from Streptomyces sp. strain
PMF can be said to be an α-β-α-β-α-sandwich. The
overall dimensions of PLD, as seen in Figure 2b, are
about 60 Å in diameter with a height of about 48 Å. The
depth or length from the presumed membrane-attached
side of the enzyme to the opposite end (normal to the
paper plane in Figure 2b) is about 42 Å. The structure is
composed of two tightly interacting domains with very
similar topology, and the overall structure is strikingly
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Figure 1
Stereographic illustration of PLD from
Streptomyces sp. strain PMF colored from
dark blue to red according to the amino acid
sequence. Two flexible loops (dashed and
labeled L1 and L2, accordingly) are seen at
the right-hand side, which is the part of the
enzyme that docks onto the membrane when
hydrolysis takes place. Two phosphate ions
(red) are found on the surface of the protein,
one located at the interface between two
independent crystallographically related
molecules, and the other in the active site of
the protein, which is located in the center of
the figure. This figure was created using
BOBSCRIPT [44,45]. 
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Structure
similar to the structure of the dimer of the endonuclease
(nuc) [10] from S. typhimurium. 
Although the two rotated α helices in the center of the mol-
ecule are distant from the active site, they intersperse the
two β sheets in the structure, and it seems probable that they
are structurally important. These helices provide the neces-
sary scaffolding or frameworkfor keeping the active site in an
open and accessible conformation so that substrate can enter. 
The active-site region of the protein is built up of identi-
cal residues from each domain, leading to an almost exact
twofold axis running through the active-site-bound phos-
phate present in this structure (see Figure 3).
The topology of both β sheets is similar except for the first
β strand (β1) in the N-terminal β sheet, which is not
present in the C-terminal β sheet. The two β sheets are
numbered (0)17652348, where (0) corresponds to β1.
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Figure 2
Topology and tertiary structure of PLD. 
(a) Overall topology of PLD from
Streptomyces sp. strain PMF. Modified figure
from TOPS [46]. The N-terminal 260
residues are shown in light blue and the
remainder of the protein is colored in dark
blue, in order to separate the two domains.
(b) Stereographic overview of the tertiary
arrangement of the protein. Helices are
shown in red and strands in yellow. The
protein is viewed from the outer membrane,
and the active-site-bound phosphate can be
seen in the center of the protein. This Figure
was created using BOBSCRIPT. 
(c) Stereographic presentation of the Cα
trace of PLD, made using BOBSCRIPT. The
orientation of the protein is as in (b).
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Strands 0, 5, 7 and 8 are antiparallel to the rest. The two 
β sheets are rotated by about 75° with respect to each
other, and the central parts of each domain can be super-
imposed by a pseudo-twofold rotation axis running almost
perfectly through the active site (Figures 2,3 and see later).
Assignment of amino acids
The determination of the tertiary structure of a protein
from experimental electron density maps is somewhat
hampered by lack of the primary sequence even at 1.4 Å
resolution. In this case, however, the shape and quality of
the electron density permitted unambiguous assignment
of most of the amino acids. The first amino acid residues
that were identified and positioned were methionines and
cysteines, because their sulfur atoms were visible at a high
sigma level in the experimental maps. This is visualized in
Figure 4a, where the solvent-flattened map at 1.4 Å reso-
lution is shown with the refined model. The same map at
a 5σ level is shown in red. The same view for the final
map is shown in Figure 4b. The histidine residues and the
aromatic amino acid residues phenylalanine, tyrosine and
tryptophan were also readily identified, as were the major-
ity of lysine, arginine, leucine, isoleucine, proline, glycine,
alanine and serine sidechains. Valine and threonine
residues, having an identical shape, can still be separated
because the threonine Oγ1 atom in most cases forms
hydrogen bonds to other residues, and the valine
sidechain in many cases forms part of a hydrophobic
cluster. Aspartic acid/asparagine and glutamic acid/gluta-
mine can, in some cases, be distinguished by their hydro-
gen-bonding pattern, and in some cases their refined
temperature factors. In places where the available
sequences had no consensus, however, the choice was
made from the fact that asparagine and glutamine are
more likely to be buried in the structure than their respec-
tive counterparts, aspartic acid and glutamic acid. Compar-
ison of the resulting X-ray sequence with sequences from
similar Streptomyces and Streptoverticillium species showed
that the sequence identity is very high. The sequences of
several peptide segments from Streptomyces sp. strain
PMF, which were obtained in our laboratory during the
model building and refinement stages, were largely in
agreement with the X-ray sequence (Figure 5). The X-ray
sequence has enabled the construction of a probe, which
at the time of submission has enabled partial gene
sequencing in a region including one of the disordered
loops (382–389), as well as one of the active-site motifs
(448–465). All the conserved regions from the sequences
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Figure 3
Two-dimensional presentation of the active
site and the bound phosphate molecule.
Water molecules in the active site have been
omitted for clarity. Atoms are shown in
standard colours and bond distances are
given in Å. This figure was created using the
programs HBPLUS [47] and LIGPLOT [48].
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Structure
match regions in the X-ray structure. Figure 4a shows a
portion of the solvent-flattened and phase-extended map
from the MAD phases; the final model superimposes well
onto the initial maps and allows the inclusion of most of
the correct amino acid residues into the experimental
maps. There is still some ambiguity, particularly in two
loop regions (residues 127–128 and 382–389) where there
is no electron density, but overall the final model is of
high quality and has stereochemical quality at or even
above the average of most of the three-dimensional struc-
tures determined at this resolution.
Phosphate geometry and environment, identification of an
active site
As determined initially, the structure contained a
tungstate ion, which was used to solve the phase problem
(see the Materials and methods section). The crystalliza-
tion, however, was carried out using a citrate-phosphate
buffer. Refinement of the model that was built from the
MAD data against the data collected in the presence of
inorganic phosphate clearly revealed one phosphate mol-
ecule occupying the same position as the tungstate mol-
ecule. Phosphate and tungstate were later shown to be
competitive inhibitors for the enzyme (SS, unpublished
observations). In addition, a second phosphate molecule
was identified on the surface of the enzyme. The two
phosphate molecules located in the native structure were
refined to the expected tetrahedral geometry; however,
their environments are very different. The best-defined
phosphate molecule is bound in the active site and has a
well-defined overall shape and hydrogen-bonding
pattern. This phosphate molecule appeared both in the
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Figure 4
Electron-density maps. (a) Experimental
solvent-flattened and phase-extended map from
DM [41] to 1.4 Å resolution and the refined
model. The electron density map is contoured
at 1.1 times the rms deviation in gray and at
5σrms in red. The two methionine residues and
the disulfide bridge are clearly visible in the
experimental maps at the high σ level. This
figure was created using BOBSCRIPT.
(b) 2mFo–DFc SigmaA-weighted [49] electron-
density map showing the same region of the
protein calculated after the final refinement
round, contoured at 1.5σrms.
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2mFo–DFc and in the mFo–DFc σΑ-weighted maps
when the native structure factors were refined against the
model. The second phosphate molecule, however, is on
the interface between three independent molecules and
could only be refined when the occupancy was lowered
to 0.5. The hydrogen-bonding pattern of the two mol-
ecules are also different with the active-site-bound phos-
phate forming six protein interactions as can be seen in
Figure 3, whereas the other phosphate has three protein
interactions only (one from each molecule). The active-
site-bound phosphate molecule might well adopt the
same orientation as the phosphate head group of a phos-
pholipid substrate during initial binding to the enzyme
and subsequent hydrolysis. Thus,   the structure of PLD
with phosphate in the active site might provide insight
into the binding of phospholipid, and identify which
residues are responsible for substrate binding and cataly-
sis. It can be seen in Figure 3 that the residues in close
contact with the phosphate head group of the substrate
are histidine, lysine and asparagine, with one of each
from each of the two domains in the protein. The most
interesting residues, from a catalytic point of view, are
the two histidines. They have relatively tight interactions
with the phosphate group and are the most potent ones
to perform the hydrolysis of the bound phospholipid in
the substrate-binding pocket of the enzyme. 
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Structure
Multiple sequence alignment of PLD encoded from Streptomyces
(St.ac, Streptomyces acidomyceticus; St.an, Streptomyces
antibioticus; St.sp, Streptomyces sp.) and Streptoverticillium (Stv.cinn,
Streptoverticillium cinnamoneum) species, and portions of the
sequence of PLD from Streptomyces sp. strain PMF (pept.) obtained in
our laboratory, or at a later stage from the gene sequence (residues
371–484), and on top the experimentally determined sequence of PLD
from Streptomyces sp. strain PMF obtained using X-ray crystallography
(X-ray). Secondary structure elements are represented by red cylinders
(α helices) or yellow arrows (β strands) and are as defined by DSSP
[13]. Light grey regions denote residues conserved in at least four
sequences describing bacterial PLDs. Boxes represent the duplicated
and conserved motifs 1–4 [9]. In these regions, the sequences for nuc
(aligned twice and denoted nuc-A and nuc-B in the alignment) from
Salmonella typhimurium and human PLD1 have been added. Asterisks
in the catalytically critical regions (motifs 3 and 4) denote residues
conserved in most PLD superfamily members. Brackets (e.g., <19>)
denote the number of residues intervening the aligned residues.
Dashes represent deletions or regions in the X-ray sequence (residues
127–128 and 382–389) with undefined electron density. The figure
was made using ALSCRIPT [50]. 
Multiple sequence alignment [7,9,14] has shown that the
endonuclease nuc from S. typhimurium, a small 155
residue-protein, shows a surprising sequence similarity to
mammalian, plant and bacterial PLDs. This is particularly
true for the residues in the vicinity of the active site. As
mentioned already, multiple sequence alignment has
identified a PLD superfamily, in which the common
denominator is that the proteins have been shown to be,
or are assumed to be, phosphate-binding proteins. In con-
trast to the majority of the members of the PLD super-
family, nuc is a small protein, and the primary structure
has only one repeat of the predicted active-site residues.
In the three-dimensional structure, however, nuc forms a
dimer with a crystallographic twofold axis directly through
the active-site-bound tungstate ion [10]. Therefore, the
active sites and their surroundings in the structures of
PLD from Streptomyces sp. strain PMF and nuc from 
S. typhimurium are very similar. One important difference,
however, is the coordination of the two histidine residues
in the active sites of the two structures. In the three-
dimensional structure of nuc, they are restricted by the
crystallographic symmetry and have identical surround-
ings and charge. Both histidine residues have hydrogen
bonds from their imidazole ring nitrogens (Nδ1 and Nε2)
to the tungstate molecule and to one glutamic acid. This
leads to a bridging of the imidazole rings between the glu-
tamic acid and the tungstate molecule. In PLD, only one
of the histidine residues (His448) is bridged by hydrogen
bonds in this fashion, and instead of a glutamic acid, an
aspartic acid (Asp202) forms a hydrogen bond to one of the
imidazole nitrogens (Nδ1). The other histidine residue
(His170) is only hydrogen bonded to the phosphate mol-
ecule, and in this case, Nδ1 of the imidazole ring partici-
pates in this bond. Oδ1 of a second aspartic acid (Asp473)
is 5.3 Å away from the Nδ1 atom of His170. It is strange
that these two residues are so far apart and this might be
caused by the binding of the phosphate molecule, which
might be able to penetrate deeper into the active site and
replace the protein–protein intramolecular interactions by
the relatively strong hydrogen bond between His170 and
one of the phosphate oxygens. This is indicated by the
tungstate-inhibited structure of PLD from Streptomyces sp.
strain PMF in which the sidechain of His170 is oriented
with the Nε2 atom pointing directly towards the tungsten
atom. The distance between the tungsten atom and the
Nε2 atom is 2.33 Å. In this orientation, His170 Nδ1 forms
an interaction with Asp473 Oδ1. This could indicate that
His170 is the nucleophile in the catalytic reaction, as the
other probable protein nucleophile, His448, is positioned
considerably further away from the tungsten atom, with a
distance of about 3.5 Å between the tungsten atom and
the His448 Nε2 atom (data not shown). The role of the
second histidine (His448) is then most likely to activate a
water molecule being the second nucleophile in the reac-
tion mechanism. It should be noted that this observation
is in disagreement with what has been found for PLD
from Streptomyces antibioticus, in which the catalytic nucle-
ophile has been located to the C-terminal domain (His450
in PLD from Streptomyces antibioticus) [15].
Comparison with other lipolytic enzymes
The three-dimensional structures of many lipolytic
enzymes have been determined. This includes the
secretory and cytosolic phospholipases A2 (sPLA2 [16]
and cPLA2 [17]) the phosphatidyl-inositol (PI), phos-
phatidyl-choline (PC) specific phospholipase C and α
toxin (PI-PLC from both bacterial [18] and mammalian
sources [19], PC-PLC from Bacillus cereus [20], and the α
toxin from Clostridium perfringens [21]), as well as many
triacylglycerol lipases, including cutinase [22], and
fungal lipases [23]. All members of the triacylglycerol
lipase family share the common α/β-hydrolase fold,
having one mainly parallel β sheet (except for strand 2),
surrounded on both sides by α helices. Some of the
family members have an extra antiparallel strand (strand
9). In order to search for structural similarities among the
above mentioned structures of lipolytic enzymes, the
starting point is to look for conservations within their
overall fold. No such conservation can be seen that
includes all the members of the lipolytic enzymes but
most of the members have an α/β-hydrolase fold, which
is common to many esterases and other hydrolytic
enzymes [24,25], or they show similarity to this fold. One
example is cPLA2, which shows conservation in most of
the strand directions and in that it contains a nucle-
ophilic elbow. The reaction mechanism of cPLA2 is dis-
tinct from other acyl hydrolases, however, as it contains a
catalytic diad instead of the usual triad [17]. 
A DALI (distance matrix alignment) [26] database search
for similar three-dimensional structures using the refined
model of PLD as the target, did not produce any
deposited structures that are strikingly similar to PLD,
except for the already mentioned structure of nuc [10].
The best fit in the database search was obtained for cuti-
nase from Fusarium solani (PDB code 1cex [22]), a
member of the lipase family and one of the smallest of the
α/β-hydrolases. Cutinase has only 197 residues, a Z score
of 3.3, as defined by the DALI software (structure pairs
with Z scores below 2 are structurally dissimilar), and a
root mean square (rms) deviation of 4.48 Å for the 86
aligned Cα atoms. Optimization of the structural align-
ment using the available tools in the graphical program O
[27] gave an rms deviation of 1.87 Å for 63 aligned atoms.
Superpositioning of these atoms in the two structures
showed that a region including the strands β3, β4 and β5
in PLD superimposes well onto strands β3, β5 and β6 in
cutinase (following the α/β-hydrolase nomenclature).
Otherwise, the structures are completely different. Rat
PI-PLC-δ1 (isozyme δ-1, PDB code 1djx [28]) had a Z
score of 3.0 and an rms value of 10.9 Å for 117 Cα atoms,
which could be optimized to 2.11 Å for 56 Cα atoms in O
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[27]. It was striking that the same region in PLD superim-
posed onto both cutinase and PI-PLC-δ1, especially con-
sidering that cutinase is a mixed α-β-α-structure with a
parallel β sheet, whereas the aligned part of PI-PLC-δ1 is
an α/β (TIM) barrel. Another structural alignment data-
base search was performed using the program DEJAVU
[29], again looking for proteins having a similar overall
fold as PLD. The best score, as decided from graphical
inspection of two superpositioned models, was obtained
against the eukaryotic DNA polymerase processivity
factor PCNA (PDB code 1plq [30]) with a score value of
1.74 and an rms deviation of 1.88 Å for six fitted secondary
structure elements, all being β strands. The β strands
fitted were β1, β10, β11, β14, β15 and β16 in PLD. In
addition to these six β strands, another β strand aligns well
but has different strand direction in the two proteins (β12).
From Figure 2a, it can be seen that all these β strands are
close to each other and are essential parts of one of the β
sheets in the structure.
Sequence and structural comparison to other members of
the PLD superfamily
Sequence alignment of PLD from several Streptomyces
species shows that a number of regions are conserved
among all the species. Calculating the sequence identity
between the experimental X-ray sequence of PLD from
Streptomyces sp. strain PMF and PLDs from other Strepto-
myces sequences, showed that the sequences from Strepto-
myces acidomyceticus [31], Streptomyces antibioticus [32] and
Streptomyces sp. [33] have 74.3%, 72.1% and 69.9%
sequence identity, respectively, when compared with the
sequence obtained from the refined X-ray structure of
PLD from Streptomyces sp. strain PMF. A recently
deposited sequence encoding PLD from Streptoverticil-
lium cinnamoneum [34] has a surprisingly high sequence
identity of 78.3% when compared with the X-ray
sequence of PLD from Streptomyces sp. strain PMF. An
overview of the aligned sequences of PLD from Strepto-
myces and Streptoverticillium species, as well as the experi-
mental X-ray sequence of PLD from Streptomyces sp.
strain PMF is shown in Figure 5. This figure also includes
the conserved regions of the sequences of nuc [35] from
S. typhimurium aligned twice, and human PLD1 [14]. A
sequence alignment of one of the domains of the X-ray
sequence of PLD from Streptomyces sp. strain PMF
against the other domain did not yield any striking results
apart from regions already found to be duplicated in the
primary structures of PLD from both bacterial, plant,
yeast and mammalian sources [7,9,14]. These involve the
active-site regions including the conserved residues
responsible for substrate binding and hydrolysis, as well
as regions of more general character. From a structural
point of view, the topology diagram shown in Figure 2a,
clearly indicates that the two domains have a common
origin, and the structure clearly consists of two domains
related by a pseudo-twofold rotation axis running through
the active-site-bound phosphate. The region most clearly
duplicated in the two domains, however, is the active-site
region containing residues 170–187 and 448–465. These
regions mainly share the same primary and secondary
structural elements. The conserved aspartic acid in the
HXK(X)4D motif that exists for many members of the
PLD superfamily (Asp177 and Asp455 in PLD from
Streptomyces sp. strain PMF), was initially believed to be
involved directly  in the catalytic process. Similarly to
what is already shown in the crystal structure of nuc [10],
these these conserved residues are indeed positioned a
long way (about 30 Å) from the active site of PLD from
Streptomyces sp. strain PMF. As in nuc, these residues are
involved in several intramolecluar interactions. Except for
the already mentioned region, there are no striking
sequence similarities from one domain to the other. The
suggestion of an ancient gene duplication and fusion
event seems to be valid. When residues from the active-
site regions in both domains were chosen and structurally
aligned using the tools available in O [27], several sec-
ondary structural elements could be superpositioned onto
each other. If the enzyme was picked twice and one mol-
ecule was superpositioned onto the other, a total of 251
Cα atoms from each molecule could be superpositioned
with an rms deviation of only 2.05 Å. Regarding the topol-
ogy of the two domains, there seems to be a conservation
of the directionality and position of the β strands in each
of the two β sheets (the one exception being the very first
β strand, β1, which is not duplicated), and most of the α
helices are positioned roughly in the same fashion in the
two domains, protecting the mainly hydrophobic β strands
from the hydrophilic surroundings. Results from the
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Figure 6
Simplified internal sequence and structural
alignment of PLD from Streptomyces sp. strain
PMF. PLD is divided into two domains and one
domain is aligned onto the other. Filled boxes
represent predicted conserved motifs from
multiple sequence alignment; bordered boxes
represent structurally aligned motifs. The regions
denoted motifs 1–4, are the motifs already
found to be conserved from multiple sequence
alignment of PLD and its homologues [9].
Motif 1 Motif 2 Motifs3–4
Domain A: a 1 a 2 b 1 a 3 b 2 - a 4 b 3 a 5 b 4  a 6 - b 5 b 6 b 7 a 7 b 8     a 8 b 9 a 9
Domain B: b 10 a 10 a 11 b 11 a 12 b 12 a 13-a 14 a 15 b 13 b 14 b 15 - b 16 a 16-a 17 b 17 a 18
Structure
multiple sequence alignment and structural alignment are
summarized in Figure 6. 
When the topology of PLD is compared with the reported
topology and ‘domain organization’ between two crystallo-
graphically related molecules in the crystal structure of nuc
[10], it becomes apparent that the topology, that is the
strand direction and the orientation of the α helices, to
some extent is conserved from one structure to the other. It
is possible to align the primary structure of nuc twice
against the sequence of PLD as determined using X-ray
crystallography; that is, each domain of PLD can be aligned
against the primary structure of nuc. It is also possible to
align the structure of a dimer of nuc from S. typhimurium
onto the structure of PLD from Streptomyces sp. strain PMF.
Doing this gives an overall rms deviation of roughly 4 Å for
all Cα atoms of nuc onto the most similar residues in PLD.
This alignment is shown in Figure 7, and shows that the
two active-site regions are indeed very similar, although
more distant regions differ more. It seems that the structure
of nuc from S. typhimurium provides a minimal structural
scaffold for hydrolysis of the phosphodiester backbone
common within the majority of the members of the PLD
superfamily of proteins. Recombinant nuc is a small protein
consisting of only 155 amino acid residues. The secondary
structure elements seem to be densely packed, having very
short interconnecting loops. As nuc is known to recognize
both single- and double-stranded DNA as well as the artifi-
cial phosphodiester substrate bis (4-nitrophenyl) phosphate
[11], it might be less specific than most other members of
the PLD superfamily, and therefore have a more solvent-
exposed active site than that, for example in the structure
of PLD from Streptomyces sp. strain PMF, in which the
active site is deeply buried within the protein. In order to
determine which residues are responsible for the substrate
specificity of PLD, the regions between the active site and
the surface need to be examined in detail. The active-site
entrance (entrance of the substrate-binding pocket) is
cone-shaped with a width  across the top of about 30 Å.
The active-site-bound phosphate is approximately 13 Å
from residues on the lip of the entrance. In the recent
structure of the human cytosolic PLA2 [17]), it is specu-
lated that a flexible lid is the reason for the interfacial acti-
vation [36] of that enzyme. In PLD, two such flexible
regions (loops) are found, both being positioned relatively
close to the active site, in the region of the enzyme
believed to be in contact with the membrane when phos-
pholipid catabolism takes place. When one of the domains
in the protein is superpositioned onto the other as
described previously, the two loops can be superpositioned
as well; that is, they occupy roughly the same position in
space. One of the loops is of particular interest (residues
382–389) both in that it is relatively long and that it is
absolutely conserved within all Streptomyces and the one
Streptoverticillium sequence identified so far. The function
of the loops might be to act as a lid in order to shield the
hydrophobic parts of the active site from the surroundings,
and/or to embed the enzyme into the membrane in order
for catalysis to happen. In view of the long distance from
the active site to the surface of the protein, it is likely that
the protein is in some way brought in closer contact with
the lipid bilayer membrane and thereby the substrate
upon catalysis. 
Biological implications
The phospholipase D (PLD) superfamily of enzymes
consists of members as diverse as PLDs, a Yersinia
murine toxin, endonucleases, phosphatidyl-serine syn-
thases, cardiolipin synthases and poxvirus envelope pro-
teins of unknown function. The common denominator
of these proteins is their ability to bind a phosphodiester
moiety in their active site. The active site region of the
PLD superfamily members consists of a conserved
motif, the HXK(X)4D motif (or the HKD motif). Most
of these proteins contain two such motifs, a few excep-
tions are reported, for example, the 16 kDa endonucle-
ase nuc [35] which contains one such motif only. The
crystal structure of nuc [10] reveals that it is crystallized
as a dimer with a crystallographic diad running through
the active site to form a single active site from a dimer. 
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Figure 7
Structural alignment of phosphate-inhibited
PLD from Streptomyces sp. strain PMF (red)
onto a dimer of tungstate-inhibited nuc (PDB
code 1bys) from Salmonella typhimurium
(blue and green). 
Structure
Unlike nuc, the crystal structure of the 54 kDa PLD
from Streptomyces sp. strain PMF reported here contains
two domains and makes up one active site from a
monomer. Except for the differences in size between the
two proteins, the overall impression is that they are excep-
tionally similar considering the fact that the two enzymes
are evolutionarily very divergent. The proposed reaction
mechanism for nuc [10] is very likely to be valid both for
PLDs and for other members of the PLD superfamily
being able to perform catalysis on phosphodiester bonds. 
The fact that the crystal structures of PLD from Strepto-
myces sp. strain PMF and the published crystal structure
of nuc have overall similarity will be helpful in pointing
out the respective regions in the two structures that are
crucial for the different substrate specificities of nuc and
PLD.
Materials and methods
Crystallization conditions and heavy-atom derivatives
PLD from Streptomyces sp. strain PMF was purified as described
previously [37]. Crystals were obtained using the sitting-drop vapor
diffusion method and two sets of conditions: 0.2 M ammonium
acetate, 0.1 M citrate/phosphate buffered at pH 5.4 and 27.5% poly-
ethylene glycol (PEG) 4K; or 0.2 M ammonium sulfate, 0.1 M sodium
acetate buffered at pH 5.4 and 27.5% PEG 4K. The first set of condi-
tions gave crystals that were larger and diffracted to higher resolution
than the latter. Details about crystallization will be presented else-
where [38]. Crystals from both conditions belong to the monoclinic
spacegroup P21 with cell parameters a = 57.28 Å, b = 57.42 Å,
c = 68.7 Å, β = 93.17°. The incorporation of sodium tungstate was
carried out by backsoaking the crystals in a phosphate- and sulfate-
free stabilizing solution prior to the addition of 10 mM of sodium
tungstate. Both the crystallizing and the stabilizing solutions also
serve as cryoprotecting solutions, because of the relatively high con-
centration of PEG 4K. All data for the MAD experiment were mea-
sured from the same crystal at 100K.
Data collection and processing
Data for the native data sets with and without bound phosphate were
collected at the Swiss-Norwegian Beamline (SNBL), ESRF (Greno-
ble, France) using a MAR Research 300 imaging plate detector
system, and data for the MAD experiment were collected at station
BM14, ESRF (Grenoble, France), using a MAR Research 345
imaging plate detector system in the 345 mm scanning mode with
150 µm pixel size. A XANES (X-ray absorption near edge structure)
scan of the W LIII- absorption edge clearly showed the incorporation
of an anomalous scatterer into the soaked crystal (Figure 8a). 
Data sets were collected at the whiteline (pk; λ1 in Figure 8b), having
the maximum anomalous signal (maximum f′′), the inflection point (pi;
λ2 in Figure 8b), for the rising edge where the dispersive signal is at
its minimum (highest absolute value of f′), the second inflection point
(pi2; λ3 in Figure 8b), on the falling edge where the dispersive signal
is at its maximum (lowest absolute value of f′), and finally a remote
wavelength (re; λ4 in Figure 8b), in this case chosen at 0.873 Å,
where the dispersive signal is known to have a small value, and the
anomalous signal still is of considerable size. Data collection statistics
for the MAD data collection as well as the same statistics regarding
the data collected on the native enzyme with and without bound PO4
is presented in Table 1.
Data collected for MAD purposes were indexed with the program
DENZO [39], using fixed unit cell parameters and crystal orientation
matrices for all four wavelengths in order to provide the same scaling on
all data sets. Scaling was carried out using SCALEPACK [39], retaining
the anomalous differences and the original indices of all reflections col-
lected. Each of the resulting reflection files were subsequently
processed with the CCP4 [40] programs AGROVATA, truncated using
TRUNCATE, and the reflection files for all wavelengths were merged
together with SCALEIT, with the remote wavelength chosen as the ref-
erence. Statistics from the data reduction are given in Table 2. 
Structure determination and model building
The single-heavy-atom position was readily determined from the anom-
alous Patterson maps, and was refined in MLPHARE [40]. Refinement
statistics are given in Table 3.
The relative occupancy for λ4 in Table 3 can be seen to deviate from
the expected values, because the data were collected on the falling
edge of the fluorescence scan where it is expected to have the
lowest absolute value of f′. In fact it refines to a value that is very
close to what is obtained along the rising edge. Nonetheless, λ4 con-
tributes significantly to improve the quality of the MAD phases, and
for that reason was included. 
The figure of merit (FOM) for the refined position of the heavy atom
was 0.52 for all reflections up to 1.9 Å resolution. The resulting phases
were then subjected to solvent flattening and phase extensioning using
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Figure 8
Two representations of a fluorescence scan of
the tungsten LIII edge for the crystal used in the
MAD data collection experiment. (a) The raw
data of the energy scan. (b) A normalized scan
from CHOOCH [51], estimating the dispersive
contribution (f′). The wavelengths used in the
MAD data collection are indicated in (b).
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Structure
DM [40,41] to 1.7 Å resolution giving a FOM of 0.66 for all reflections
in the remote data set and an electron-density map of excellent quality.
As native data had already been collected to 1.4 Å resolution,
however, these data were solvent-flattened and phase-extended in DM
using the MAD phases from MLPHARE [40]. The resulting FOM was
0.59, and visual examination of the electron-density map on a graphical
workstation, comparing it with the solvent-flattened MAD map to 1.7 Å
resolution, clearly showed that the higher resolution map was superior,
revealing more structural detail than the ‘lower’ resolution one, for
instance the directionality of the protein backbone. Both maps were
used in the model building process, however, because the overall con-
nectivity of the 1.7 Å map was somewhat better. 
The initial atomic model was built from the experimental maps using the
graphical program O [27]. The quality of the maps allowed the place-
ment of 465 residues into the electron density. This accounts for about
95% of the present model comprising 494 amino acid residues. As our
information was only for peptide fragments, sequences encoding PLD
from similar species were used in the process of tracing the amino acid
backbone. These sequences were from Streptomyces acidomyceticus
[31], Streptomyces antibioticus [32] and a sequence from Strepto-
myces sp. [33], which is somewhat different from the one reported
here. Sequenced peptide fragments from the Streptomyces sp. PLD
herein reported comprised 107 amino acids and gave useful informa-
tion in the initial model building steps.
Refinement
This initial model was subjected to refinement in X-PLOR [42] using all
reflections in the range 15–1.9 Å. The R values after the refinement
were 33.4% and 29.3% for the test and working sets of reflections,
respectively. The subsequent refinement and model building rounds
were performed using all data in the range 15–1.4 Å. After conver-
gence in X-PLOR, refinement was continued using SHELXL [43]. Sta-
tistics from the final refinement round can be seen in Table 4. The
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Table 1
Data collection statistics for the native and MAD data sets.
Crystal Space group Resolution (Å) a (Å) b (Å) c (Å) β (°) Source
MAD, WO4 P21 1.9 (1.7)* 57.61 56.90 68.95 93.67 ESRF, BM14
Native, PO4 P21 1.4 57.28 57.42 68.70 93.17 ESRF, BM01
*The number in the parentheses is the resolution for the remote wavelength of the MAD data collection.
Table 2
Statistics from data reduction. 
Crystal λ Resolution No. Redundancy Total Unique reflections Friedel pairs Rmerge§ I/σI#
(Å) (Å) measured* completeness† completeness‡ (%) (%) (%)
MAD, pk λ1 = 1.21427 1.9 (2.0–1.9) 129,032 3.7 (3.5) 35,237 99.8 (99.7) 99.2 (96.1) 5.2 (20.2) 9.4 (3.5)
MAD, pi λ2 = 1.21475 1.9 (2.0–1.9) 129,022 3.7 (3.5) 35,229 99.8 (99.5) 99.2 (96.2) 4.8 (22.1) 9.7 (3.2)
MAD, pi2 λ3 = 1.21381 1.9 (2.0–1.9) 135,807 3.7 (3.5) 35,241 99.9 (99.6) 99.2 (94.7) 4.8 (23.4) 10.8 .8 (3.1)
MAD, re λ4 = 0.88553 1.7 (1.79–1.7) 185,333 3.8 (3.7) 48,958 99.6 (99.8) 99.3 (99.4) 4.3 (25.0) 11.8 (2.9)
Native, PO4 0.873 1.4 (1.48–1.4) 261,275 3.0 (3.0) 86,900 99.2 (99.2) – 5.8 (20.4) 7.4 (3.4)
Numbers in parentheses represent values for the highest resolution
bin. *Number of observations prior to scaling. †Completeness of the
unique data sets. ‡Completeness of the anomalous data sets.
§Rmerge = (ΣhΣi|Ii(h)–<I(h)>|/(ΣhΣiI(h), where Ii(h) is the ith
measurement of reflection h and <I(h)> is the weighted mean of all
measurements of h. #Intensity signal-to-noise ratio. pk, pi, pi2 and re
are defined in the text and Figure 8.
Table 3
Statistics after refinement of the heavy-atom position in MLPHARE.
Crystal λ (Å) Resolution (Å) f′* f′′† Rcullis‡ Phasing power§
(acentric) (centric) (anom) (acentric) (centric)
WO4, re λ3 = 0.88553 1.7 0.000 6.854 – – 0.77 – –
WO4, pi λ2 = 1.21475 1.9 –18.822 10.836 0.70 0.57 0.77 1.63 1.36
WO4, pk λ1 = 1.21427 1.9 –10.789 17.515 0.81 0.73 0.68 1.06 0.92
WO4, pi2 λ4 = 1.21381 1.9 –18.408 8.938 0.72 0.58 0.80 1.53 1.39
*Refined dispersive occupancy relative to the remote wavelength as
given by MLPHARE. †Refined anomalous occupancy from MLPHARE.
‡Rcullis = Σh| | |Fderiv(h)|–|Fnat(h)| |–|FH| | /Σh| |Fderiv(h)|–|Fnat(h)| |, where FH
is the calculated heavy-atom structure factor. §The phasing power is
defined as (rms FH/rms lack-of-closure) summed over the reflections
used in the heavy-atom refinement.
present model is connected into one polypeptide chain except for two
loop regions comprising residues 127–128 and 382–389, both being
close to the active site, however the latter being the closest and
thought to be important in either substrate recognition, or acting as a
lid to cover the hydrophobic parts of the active site from the surround-
ings. It is an interesting fact that this loop is conserved for all the
sequences of bacterial origin. 
Accession numbers
The atomic coordinates have been deposited in the Protein Data Bank
with accession code 1F0I and will be on hold for one year.
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